Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01992861 · ClinicalTrials.gov registry record
MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer
A clinical trial, sponsored by University of Washington.
- Terminated
- Registry status
- 51
- Enrollment target
NCT01992861 is a clinical trial that was terminated before completion, run by University of Washington. The registered enrollment target is 51 participants.
The verdict
NCT01992861 was terminated before completion, sponsored by University of Washington.
- TERMINATED
- Registry status
- 51 participants
- Enrollment target
Study Summary
This trial studies magnetic resonance imaging (MRI) and positron emission tomography (PET) imaging in predictive treatment response in patients with stage IB-IVA cervical cancer. MRI is a procedure in which radio waves and a powerful magnet linked to a computer are used to create detailed pictures of areas inside the body. PET is a procedure in which a small amount of radioactive glucose (sugar) is injected into a vein, and a scanner is used to make detailed, computerized pictures of areas inside the body where the glucose is taken up. Comparing results of diagnostic procedures, such as MRI and PET, done before, during and after radiation and chemotherapy may help doctors predict a patient's response to treatment and help plan the best treatment.
Interventions
- PROCEDURE Computed Tomography
- PROCEDURE Magnetic Resonance Spectroscopic Imaging
- RADIATION Fludeoxyglucose F-18
- PROCEDURE Diffusion Weighted Imaging
- PROCEDURE Dynamic Contrast-Enhanced Magnetic Resonance Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2014-02-14 |
| Est. Completion | 2022-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01992861
The ClinicalTrials.gov registry entry for NCT01992861 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Computed Tomography is the first listed.
NCT01992861 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01992861 about?
NCT01992861 is a clinical study titled "MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer". This trial studies magnetic resonance imaging (MRI) and positron emission tomography (PET) imaging in predictive treatment response in patients with stage IB-IVA cervical cancer. MRI is a procedure in which radio waves and a powerful magnet linked to a computer are used to create detailed pictures o...
What is the current status of trial NCT01992861?
This trial is currently terminated. The enrollment target is 51 participants. The study started on 2014-02-14. Estimated completion is 2022-01.
What interventions are being tested in trial NCT01992861?
The interventions under investigation include: Computed Tomography (PROCEDURE), Magnetic Resonance Spectroscopic Imaging (PROCEDURE), Fludeoxyglucose F-18 (RADIATION), Diffusion Weighted Imaging (PROCEDURE), Dynamic Contrast-Enhanced Magnetic Resonance Imaging (PROCEDURE).
Who is sponsoring clinical trial NCT01992861?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.